Capital Allocation
Avano Capital
A venture and private equity fund dedicated to the global development of neuromodulation infrastructure.
Structure
VC and PE fund
Target fund size
€2.2B
Minimum viable fund
€600M
Mandate
Allocates capital to research and to clinical facilities, sized against what the clinics actually need.
Avano Capital allocates across real estate, artificial intelligence, neuromodulation hardware, and fund-of-funds positions. Separating those asset classes hedges risk at the fund level while allowing the firm to integrate vertically across a market that is otherwise fragmented between device makers, imaging centres, and outpatient clinics.
What sets it apart
In practice
Where the work happens
Elsewhere in the loop
The other two entities
Avano will advance the global practice of medicine
We work with limited partners, clinical institutions, and neurotechnology founders building toward the same thing. If that is you, we would like to hear from you.